Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cellsBrian G. Till, Oliver W. Press, Xiaojun Qian et al.|Blood|2008Cited by 719
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial resultsBrian G. Till, Oliver W. Press, Michael C. Jensen et al.|Blood|2012Cited by 530
Ibrutinib Monotherapy in Relapsed or Refractory, Transformed Diffuse Large B-cell LymphomaSolomon A. Graf, Ajay K. Gopal, Ryan D. Cassaday et al.|Clinical Lymphoma Myeloma & Leukemia|2020Cited by 13